Assenagon Asset Management S.A. Bridge Bio Pharma, Inc. Transaction History

Assenagon Asset Management S.A.

$60.5 Billion
Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 350,411 shares of BBIO stock, worth $16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

350,411

Previous 1,120,933 68.74%

Holding current value

$16 Million

Previous $38.8 Million 60.95%

% of portfolio

0.02%

Previous 0.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$30.14 - $45.12 $23.2 Million - $34.8 Million	-770,522 Reduced 68.74%	350,411 $15.1 Million
Q1 2025 Apr 15, 2025	BUY	$28.12 - $37.59 $30.8 Million - $41.2 Million	1,096,799 Added 4544.62%	1,120,933 $38.8 Million
Q3 2024 Oct 23, 2024	SELL	$23.91 - $31.3 $5.33 Million - $6.97 Million	-222,761 Reduced 90.22%	24,134 $614,000
Q2 2024 Jul 18, 2024	BUY	$23.0 - $31.04 $5.52 Million - $7.45 Million	239,900 Added 3429.59%	246,895 $6.25 Million
Q1 2024 Apr 24, 2024	SELL	$27.35 - $40.45 $813,361 - $1.2 Million	-29,739 Reduced 80.96%	6,995 $216,000
Q4 2023 Jan 17, 2024	SELL	$24.02 - $43.89 $96,656 - $176,613	-4,024 Reduced 9.87%	36,734 $1.48 Million
Q3 2023 Nov 06, 2023	SELL	$16.89 - $35.01 $1.86 Million - $3.86 Million	-110,204 Reduced 73.0%	40,758 $1.07 Million
Q2 2023 Jul 25, 2023	BUY	$13.29 - $18.01 $231,751 - $314,058	17,438 Added 13.06%	150,962 $2.6 Million
Q1 2023 Apr 18, 2023	SELL	$7.17 - $18.55 $736,186 - $1.9 Million	-102,676 Reduced 43.47%	133,524 $2.21 Million
Q4 2022 Jan 12, 2023	SELL	$6.74 - $11.52 $5,816 - $9,941	-863 Reduced 0.36%	236,200 $1.8 Million
Q3 2022 Oct 27, 2022	SELL	$7.94 - $12.36 $2 Million - $3.12 Million	-252,270 Reduced 51.55%	237,063 $2.36 Million
Q2 2022 Jul 27, 2022	SELL	$5.21 - $12.14 $3.88 Million - $9.05 Million	-745,544 Reduced 60.37%	489,333 $4.44 Million
Q1 2022 Apr 25, 2022	BUY	$7.34 - $17.16 $8.98 Million - $21 Million	1,223,122 Added 10405.12%	1,234,877 $12.5 Million
Q4 2021 Feb 01, 2022	BUY	$11.38 - $53.41 $41,946 - $196,869	3,686 Added 45.68%	11,755 $196,000
Q3 2021 Oct 19, 2021	BUY	$46.87 - $64.24 $378,194 - $518,352	8,069 New	8,069 $378,000

Others Institutions Holding BBIO

# of Institutions

369

Shares Held

184M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $6.77B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Bridge Bio Pharma, Inc. Transaction History